Key Takeaways BPC-157 (Body Protection Compound-157) is a synthetic peptide with research in the gut healing area, tissue repair, inflammation support, and recovery in animals
Clin Ophthalmol
(PubMed) That doesnt automatically translate to healthier, and it certainly doesnt translate to safe to combine with other secretagogues indefinitely. A clinician-friendly framework to evaluate any peptide stack you see online If you want the full decision logic, use Metos pillar: Heres the condensed version Id use in a consult: Step 1: Define the outcome in one sentence Not fat loss. Instead: Reduce visceral adiposity and improve triglycerides in 12 weeks, or Improve return-to-running tolerance after a tendon injury. Step 2: Grade evidence, not enthusiasm Use three buckets: A: Human outcomes evidence (best) B: Human biomarker evidence (useful but indirect) C: Preclinical/mechanistic only (hypothesis) Example: Semaglutide for weight loss: A CJC-1295 for raising IGF-1: B BPC-157/TB-500 for tendon healing: often C low B , depending on claim Step 3: Avoid redundancy If two compounds push the same pathway, youre more likely to get side effects than synergy

Those numbers buy you a licensed medical provider, a 503A compounding pharmacy supply chain, individualized dosing, in-person injection training, and follow-up at the clinic
Retatrutide is currently in Phase 2 clinical trials
and had the IM 1mg day after